• Learning Objective 1: Understand the newborn screen process for cystic fibrosis (CF) and the role of the pediatrician
  • Learning Objective 2: Provide an update on the current state of CF treatments, outcomes and life expectancy​
  • Learning Objective 3: Introduce the new genetic modulator drugs that target the basic defect in CF​
Session date: 
01/04/2024 - 12:00pm to 1:00pm CST
Location: 
P-117
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kimberly Watts, MD, MSc